Nothing Special   »   [go: up one dir, main page]

Tomza‐Marciniak et al., 2018 - Google Patents

Effect of bisphenol A on reproductive processes: A review of in vitro, in vivo and epidemiological studies

Tomza‐Marciniak et al., 2018

Document ID
14964560936562177725
Author
Tomza‐Marciniak A
Stępkowska P
Kuba J
Pilarczyk B
Publication year
Publication venue
Journal of Applied Toxicology

External Links

Snippet

As bisphenol A (BPA) is characterized by a pronounced influence on human hormonal regulation, particular attention has been aimed at understanding its role in reproductive processes in males and females, as well as on fetal development. Owing to the increasing …
Continue reading at analyticalsciencejournals.onlinelibrary.wiley.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs

Similar Documents

Publication Publication Date Title
Tomza‐Marciniak et al. Effect of bisphenol A on reproductive processes: A review of in vitro, in vivo and epidemiological studies
Siracusa et al. Effects of bisphenol A and its analogs on reproductive health: A mini review
Wang et al. In utero bisphenol A exposure disrupts germ cell nest breakdown and reduces fertility with age in the mouse
Peretz et al. Bisphenol A and reproductive health: update of experimental and human evidence, 2007–2013
Dinsdale et al. Endometriosis and polycystic ovary syndrome are diametric disorders
Crain et al. Female reproductive disorders: the roles of endocrine-disrupting compounds and developmental timing
Sun et al. TMCO1 is essential for ovarian follicle development by regulating ER Ca2+ store of granulosa cells
Chiang et al. Exposure to di (2-ethylhexyl) phthalate and diisononyl phthalate during adulthood disrupts hormones and ovarian folliculogenesis throughout the prime reproductive life of the mouse
Zhang et al. 3-Nitropropionic acid induces ovarian oxidative stress and impairs follicle in mouse
Azadi et al. Zaditen (Ketotifen), as mast cell blocker, improves sperm quality, chromatin integrity and pregnancy rate after varicocelectomy
Rodríguez-González et al. Accelerated aging of reproductive capacity in male rat offspring of protein-restricted mothers is associated with increased testicular and sperm oxidative stress
Zhang et al. Maternal exposure to Di-(2-ethylhexyl) phthalate (DEHP) activates the PI3K/Akt/mTOR signaling pathway in F1 and F2 generation adult mouse testis
Kim et al. Sperm DNA fragmentation and sex chromosome aneuploidy after swim-up versus density gradient centrifugation
Hułas-Stasiak et al. Prenatally administered dexamethasone impairs folliculogenesis in spiny mouse offspring
Aitken et al. DNA damage in testicular germ cells and spermatozoa. When and how is it induced? How should we measure it? What does it mean?
Funke et al. Male reproductive tract abnormalities: more common after assisted reproduction?
Dos Santos et al. In utero and lactational exposure to fluoxetine delays puberty onset in female rats offspring
Yu et al. Transgenerational impairment of ovarian induced by 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD) associated with Igf2 and H19 in adult female rat
Martinez et al. Best laboratory practices and therapeutic interventions to reduce sperm DNA damage
Moretti et al. Cryptorchidism and semen quality: a TEM and molecular study
van den Driesche et al. Systematic comparison of the male reproductive tract in fetal and adult Wistar rats exposed to DBP and DINP in utero during the masculinisation programming window
Beltrame et al. Vitamin B12 prevents cimetidine-induced androgenic failure and damage to sperm quality in rats
Magalhães et al. Current markers for infertility in men
Veeramachaneni et al. Sequelae in male rabbits following developmental exposure to p, p′-DDT or a mixture of p, p′-DDT and vinclozolin: Cryptorchidism, germ cell atypia, and sexual dysfunction
Štiblar-Martinčič Morphometrical evaluation of germ cell apoptosis in infertile men